Skip to content
Global Access Atlas
Research brief
Public change log

What changed in policy—or in our evidence—and how the pathway changed

Entries distinguish a new external policy event from an Atlas research revision. The official source date and the date Atlas changed its content are always shown separately. The log starts on 6 August 2026; earlier dossier work forms the initial evidence baseline.

Logging since2026-08-06
Saved in this browser. No email alerts or account required.
Atlas updated
India
Pathway changeAtlas research revision
Latest cited official sourceDate not specifiedAtlas content updated2026-10-31

India: qualify regulatory, pricing and treatment-access references

Why Atlas revised this pathway

Added selected 2026 test-manufacturing, imported shelf-life, PSUR and DPCO amendments; clarified conditional clinical waivers and separate scheme, supply and later-claim checks.

Change in the Atlas pathway

Use 13 reference checks across parallel research contexts. Actual product, patient, provider, price, contract and stock decisions remain case-specific.

Affected access gates
Product and claim classificationClinical evidence and conditional waiverCommercial import or manufacture permissionOperating licence and supply readinessDPCO price-control classificationEssential-medicines policyHTA topic initiationHTA study and appraisalState and facility procurementPM-JAY treatment-package contextCGHS beneficiary and supply contextPrivate insurance and self-pay contextPost-launch obligations and access review